RecruitingPhase 2NCT07271186
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Studying Non-genetic systemic disease with glomerulopathy as a major feature
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Regeneron Pharmaceuticals
- Principal Investigator
- Clinical Trial ManagementRegeneron Pharmaceuticals
- Intervention
- ALN-ANG3(drug)
- Enrollment
- 270 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2026 – 2028
Study locations (29)
- Applied Research Center of Arkansas, Little Rock, Arkansas, United States
- Amicis Research Center, Northridge, California, United States
- Central Coast Nephrology, Salinas, California, United States
- North America Research Institute, San Dimas, California, United States
- Amicis Research Center, Santa Clarita, California, United States
- Amicis Research Center, Valencia, California, United States
- D&H Doral Research Center, Doral, Florida, United States
- AGA Clinical Trials, Hialeah, Florida, United States
- Convenient Medical Center, Hialeah, Florida, United States
- Elixia Hollywood, Hollywood, Florida, United States
- D&H Pompano Research Center, Margate, Florida, United States
- LCC Medical Research Institute, Miami, Florida, United States
- D&H National Research Centers, Inc, Miami, Florida, United States
- Regenerate Primary Medical Research, LLC, Miami, Florida, United States
- Ocean Blue Medical Research Center - Internal Medicine, Miami Springs, Florida, United States
- +14 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07271186 on ClinicalTrials.govOther trials for Non-genetic systemic disease with glomerulopathy as a major feature
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06622915Cardiac Performance Evaluation in Children With Steroid Dependent vs Steroid Resistant Nephrotic SyndromeSohag University
- RECRUITINGPHASE3NCT05914155Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic SyndromeShoichi Maruyama MD PhD
See all trials for Non-genetic systemic disease with glomerulopathy as a major feature →